Biovaxys Technology Stock Forecast

Sell candidate since Jul 31, 2026

The BioVaxys Technology Corp. stock price gained 45.31% on the last trading day (Friday, 31st Jul 2026), rising from $0.0757 to $0.110. During the last trading day the stock fluctuated 0.0910% from a day low at $0.110 to a day high of $0.110. The price has been going up and down for this period, and there has been a 49.56% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 15 thousand more shares were traded than the day before. In total, 15 thousand shares were bought and sold for approximately $1.63 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.00% during the next 3 months and, with a 90% probability hold a price between $0.0294 and $0.151 at the end of this 3-month period.

BVAXF Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). BioVaxys Technology Corp. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioVaxys Technology Corp. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.115. On a fall, the stock will find some support from the short-term average at $0.106. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, May 22, 2026, and so far it has fallen -39.66%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for BioVaxys Technology Corp. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.102 and $0.0920. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, BioVaxys Technology Corp. finds support just below today's level at $0.102. If this is broken, then the next support from accumulated volume will be at $0.0920 and $0.0839.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0001 between high and low, or 0.0910%. For the last week, the stock has had daily average volatility of 4.81%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BVAXF) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect BioVaxys Technology Corp. to open at $0.110, and during the day (based on 14 day Average True Range), to move between $0.0963 and $0.124, which gives a possible trading interval of +/-$0.0275 (+/-28.52%) up or down from last closing price. If BioVaxys Technology Corp. takes out the full calculated possible swing range there will be an estimated 28.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.102 (7.36%) than the resistance at $0.120 (9.09%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioVaxys Technology Corp. stock A Buy?

BioVaxys Technology Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.066 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.110 ( 0.0303%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk